Gene Disruptions Associated with Autism Risk

NIH | NOVEMBER 27, 2014

Autism is a complex brain disorder characterized by difficulties with social interactions and communication. The symptoms and levels of disability can range from mild to severe. The wide range of disorders is collectively referred to as autism spectrum disorder (ASD).

Many genes that are important for normal development may have a modest impact on the risk for autism spectrum disorder. Image credit NIH

Researchers previously linked less than a dozen genes to ASD. To further uncover genes that might be associated with the disorder, a large international team analyzed more than 14,000 DNA samples. More than 3,800 were from children with autism. The others were from parents and control samples of unrelated people.

The scientists looked for genetic lesions that were either inherited or de novo—spontaneous variations found in a child’s DNA but not in either parent’s. The team sequenced the exome regions of DNA, which comprise the 1% of the human genome that codes for proteins. This is in contrast to whole genome sequencing, which analyzes the entire 6 billion DNA base pairs of the human genome.

The researchers identified changes in 107 genes that are likely to contribute to the risk for ASD. More than 5% of the people with ASD had de novo loss-of-function mutations, which prevent production of a normal protein.

The researchers predicted that more than 1,000 genes may be involved in the risk for ASD, many of which will only have a modest impact on risk.

Among the genes found to be associated with a risk for ASD, many coded for proteins involved in 3 pathways important for normal development. One involves the structure of synapses, the connections between nerve cells across which brain signals travel. A second involves the remodeling of chromatin—the way DNA is packaged in cells, which can affect whether genes are turned on or off. A third pathway involves transcription, the process by which instructions in genes are read to build proteins.

Together, the findings provide a better understanding of some of the genetic and cellular changes in the pathways and processes thought to be involved in ASD. Eventually, this knowledge may help lead to potential therapies.

YOU MAY ALSO LIKE

New prognostic test could enable personalised treatment of inflammatory bowel disease

Scientists at the University of Cambridge have developed a new test that can reliably predict the future course of inflammatory bowel disease in individuals, transforming treatments for patients and paving the way for a personalised approach.

Early stimulation improves performance of bioengineered human heart cells

Researchers from Columbia University, New York City, are now able to use induced pluripotent stem cells (iPSC) to form a model of human adult-like cardiac muscle by introducing electric and mechanical stimulation at an early stage.

Physical Activity May Reduce Age-Related Movement Problems

Age-related brain lesions known as white matter hyperintensities have been linked to movement problems and disabilities later in life. These lesions, which appear as bright spots on MRI images, can be used as a proxy measure of brain white matter disease. They are thought to reflect small blood vessel disease, and have also have been associated with dementia and other health issues in older people.

New Test May Detect Pancreatic Cancer Early

Researchers have developed a blood test that could help with the early detection of pancreatic cancer, one of the deadliest forms of the disease.

Few people with peanut allergy tolerate peanut after stopping oral immunotherapy

Allergy to peanut, which is often severe, is one of the most common food allergies. Although previous studies have shown that peanut oral immunotherapy (OIT) — ingesting small, controlled amounts of peanut protein —can desensitize adults and children and prevent life-threatening allergic reactions, the optimal duration and dose is unknown.

Disrupting the gut microbiome may affect some immune responses to flu vaccination

Researchers from Stanford University found that oral antibiotics, which can kill gut microorganisms, can alter the human immune response to seasonal influenza vaccination.